Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years

OBJECTIVE: To determine long-term safety and efficacy of adjunctive clobazam for patients with Lennox-Gastaut syndrome (LGS). METHODS: Eligible patients from two randomized controlled trials (Phase II OV-1002 and Phase III OV-1012) were able to enroll in open-label extension (OLE) study OV-1004 begi...

Descripción completa

Detalles Bibliográficos
Autores principales: Conry, Joan A, Ng, Yu-Tze, Kernitsky, Lydia, Mitchell, Wendy G, Veidemanis, Rima, Drummond, Rebecca, Isojarvi, Jouko, Lee, Deborah, Paolicchi, Juliann M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Full-Length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303987/
https://www.ncbi.nlm.nih.gov/pubmed/24580023
http://dx.doi.org/10.1111/epi.12561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303987/
https://www.ncbi.nlm.nih.gov/pubmed/24580023
http://dx.doi.org/10.1111/epi.12561

Ejemplares similares